Could cause temporary or reversible harm; serious harm is unlikely.
cGMP deviations
| Distributed by / for | Direct Rx, Dawsonville, GA 30534 |
| NDC | 61919-0009-30 |
| Full product label | Montelukast Sodium Tablets, USP, 10 mg Tablets, Rx Only, Packaged as: a) 30-count bottle, NDC 61919-0009-30; b) 90-count bottle, NDC 61919-0009-90; Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534 |
| Recalling firm | Direct Rx |
| Distribution | Nationwide in the USA |
| Quantity | 90 count: 495 bottles; 30 count: 13 bottles |
| Recall initiated | 2023-03-13 |
| Report date | 2023-04-05 |
| Recall completed | 2024-06-17 |
| Recall number | D-0476-2023 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Dawsonville GA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗